| Mr Thomas Gerald Corbo, PA-C | |
|
1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 | |
| (908) 273-4300 | |
| Not Available |
| Full Name | Mr Thomas Gerald Corbo |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 1 Diamond Hill Rd, Berkeley Heights, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811501976 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 25MP00573700 (New Jersey) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 25MP00573700 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chilton Medical Center | Pompton plains, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summit Medical Group Pa | 5395642276 | 1253 |
News Archive
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
Arthrosurface has received FDA clearance to launch its cartilage surface implant system for the treatment of patello-femoral disease.
Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas - the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published yesterday, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.
A new research project, led by a team from St George's, University of London and Kingston University as well as Cardiff University, has received major funding from the National Institute for Health Research to develop personalized rehabilitation programmes to help patients live well with long Covid.
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thomas Gerald Corbo, PA-C 500 Borrie Ave, Brielle, NJ 08730-1902 Ph: (732) 403-4889 | Mr Thomas Gerald Corbo, PA-C 1 Diamond Hill Rd, Berkeley Heights, NJ 07922-2104 Ph: (908) 273-4300 |
News Archive
Ipsen, a global biopharmaceutical group, today announced that its partner Roche today announced the implementation of a risk mitigation plan in the taspoglutide Phase III programme. Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen's research is developed by Roche. This compound is similar to the natural hormone GLP-1 which has a key role in blood sugar regulation.
Arthrosurface has received FDA clearance to launch its cartilage surface implant system for the treatment of patello-femoral disease.
Scientists at Joslin Diabetes Center have found genetic regions that, when defective, allow the immune system to attack the pancreas - the first in a series of mis-steps that lead to type 1 diabetes. Armed with these findings, published yesterday, March 22, in the journal Immunity, the researchers are now trying to hone in on the exact genes involved, in mice and in human patients.
A new research project, led by a team from St George's, University of London and Kingston University as well as Cardiff University, has received major funding from the National Institute for Health Research to develop personalized rehabilitation programmes to help patients live well with long Covid.
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
› Verified 2 days ago
Denise Rizzolo, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-273-4300 Fax: 908-673-7132 | |
Lauren Baron, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8880 Fax: 908-277-8796 | |
Mrs. Marina Bella Shaferman, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Summit Medical Group, Berkeley Heights, NJ 07922 Phone: 908-277-8712 Fax: 908-673-7108 | |
Michael Steven Arbuco, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 845-987-4076 | |
Mrs. Mona Mary Sedrak, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-273-4300 | |
Mr. Steven Charles Olson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8704 Fax: 908-277-8876 | |
Thomas Dotro, PHYSICIAN ASSISTANT Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Diamond Hill Rd, Berkeley Heights, NJ 07922 Phone: 908-277-8940 |